{"id":"https://genegraph.clinicalgenome.org/r/bfa5ddeb-f0f8-4070-a203-5afd1ad86b40v2.0","type":"EvidenceStrengthAssertion","dc:description":"CTF-1 was originally evaluated for DCM by the ClinGen DCM GCEP on February 28, 2020. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on June 14 2024. As a result, the classification changed from limited to no known disease relationship. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein. CTF-1 was first reported in relation to autosomal dominant dilated cardiomyopathy in 2000 (Erdmann J et al, PMID: 11058912). Human genetic evidence supporting this gene-disease relationship includes case-level data. At least 7 variants (6 missense and 1 spice site variant) have been reported in humans. Variants in this gene have been reported in at least 10 probands in 3 publications (Erdmann et al, 2000, PMID: 11058912; Pugh et al, 2014, PMID: 24503780; Akinrinade et al, 2015, PMID: 26084686). No segregation data has been reported. This gene-disease relationship has been studied in at least one case-control study at the single variant level (Erdmann et al, 2000, PMID: 11058912), however, this variant was subsequently found to be more commonly expressed in the population than would be expected to explain disease.  There is a lack of robust human genetic evidence demonstrating this gene-disease relationship in the literature. No new publications demonstrating CTF-1 variants in DCM were identified during re-curation. Evaluation of the previously identified variants found that all but one of the variants have subsequently been found at a frequency higher than would be expected for a monogenic, pathogenic effect in population reference data sets. This gene-disease association is supported by one animal model (rat) and expression studies (Pennica et al, 1995, PMID: 7862649; Pennica et al, 1996, PMID: 8833032; Zolk et al, 2002, PMID: 12234945; Lopez et al, 2014, PMID: 24366078; Robador et al, 2011, PMID: 21771897; Lopez-Andres et al, 2012, PMID: 22733458). Two additional human expression studies (Sharif et al, 2021, PMID: 34447655; RubiÅ› et al, 2021, PMID: 34071085) were identified during re-curation. In summary, no convincing evidence for a causal role for CTF-1 and autosomal dominant DCM has been reported. Although this gene-disease assertion is supported by one animal model (rat) and multiple expression studies (human) no reports have directly implicated the gene in humans. Because of this, as well as the lack of new supporting evidence in the four year period since the previous curation, the expert panel has classified this gene as having No Known Disease Relationship for monogenic cause of DCM at this time. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on June 14 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/bfa5ddeb-f0f8-4070-a203-5afd1ad86b40","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c","calculatedEvidenceStrength":"Limited","changes":[{"id":"cg:newEvidence"},{"id":"cg:summaryChange"},{"id":"cg:sopChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2024-08-07T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2024-08-07T20:05:40.372Z","role":"Publisher"}],"curationReasonDescription":"No convincing evidence for a casual role for CTF-1 and autosomal dominant DCM has been reported. Although this gene-disease assertion is supported by one animal model (rat) and multiple expression studies (human), no reports have directly implicated the gene in humans. Because of this, as well as the lack of supporting new evidence in the four year period since the previous curation, the expert panel has classified this gene as having No Known Disease Relationship for monogenic cause of DCM at this time. ","curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a9b35c9-cb84-4e6b-ad85-21b1cf471c83","type":"EvidenceLine","dc:description":"Did not score as already scored mRNA expression in PMID: 8833032","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56e18ecd-41e2-446f-9c0c-37ef87c7a3b6","type":"Finding","dc:description":"Cloning and northern blot identifying CTF1 in mouse heart tissue.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7862649","rdfs:label":"Cloning mouse CTF1","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/085c6fdd-c0fa-436c-b4b4-3d641df17518","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf7bde90-f1ad-4771-92d7-c4ef4dbf22b8","type":"Finding","dc:description":"Expression of CTF1 in cardiomyocytes  and in mouse heart that can be induced by hypoxia","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21771897","rdfs:label":"CTF1 in cardiomyocytes","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d02f06f5-24d4-4f6d-97b0-9087f9e4a92a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b278a89e-de12-4456-83a7-0c19daffcd8e","type":"Finding","dc:description":"Found that CTF1 mRNA and protein levels were higher in the left ventricles of patients with dilated cardiomyopathy compared to normal heart.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12234945","rdfs:label":"Left ventricle CTF1 mRNA and protein expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c6434164-0537-4ec3-9408-6214da12f7e2","type":"EvidenceLine","dc:description":"Did not score; maximum number of points for function experimental evidence was previously reached from other papers (PMIDs: 21771897, 24366078, 12234945, 8833032). ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc4dec4b-f26a-48d4-a536-519db5c810f8","type":"Finding","dc:description":"In a cohort of 102 DCM patients and 27 controls, CTF-1 expression was higher in the DCM group then the control group. There was no correlation between CTF-1 expression and myocardial fibrosis on MRI in the DCM group.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34071085","rdfs:label":"DCM vs. Control CTF1 Expression ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/caebd9d4-a2bc-4b42-89c8-77e2fc57eab7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5db92cec-0f83-4004-8a2b-0fbeeed62661","type":"Finding","dc:description":"Cloning and expression of RNA (Northern blots) for CTF1 in human heart tissue.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8833032","rdfs:label":"Cloning human CTF1","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b6c7ce01-da2a-43fa-9bb3-3e2178f741b0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54aac910-b2f8-45e3-9f03-91c0f8ff3cd2","type":"Finding","dc:description":"Identified difference in CTF1 mRNA and protein levels in normal compared to hypertensive heart failure samples. Scored for expression in heart tissue not difference in patient sample as the patients had hypertensive heart failure not DCM","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24366078","rdfs:label":"Expression of CTF1 in heart failure","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c7a79ea8-fe96-4177-9689-70802fccde7d","type":"EvidenceLine","dc:description":"Did not score; maximum number of points for function experimental evidence was previously reached from other papers (PMIDs: 21771897, 24366078, 12234945, 8833032). ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/badc7d67-5e84-400d-924d-3058bc4a7c39","type":"Finding","dc:description":"When comparing 20 DCM patients and 20 healthy controls, CTF-1 mRNA levels were higher in the DCM group then in the control group. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34447655","rdfs:label":"Gene Expression: CTF1 mRNA","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6cfabc0-7b70-4f9b-81a5-4ab304404707","type":"EvidenceLine","dc:description":"Reduced score as little data to show if missense and splice site variants result in overexpression or gain of function of CTF-1.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a64600a3-2fdd-4853-bcb9-e9b49b15a19c","type":"Finding","dc:description":"CTF1 treatment in rats increased left ventricular volumes, reduced ejection fraction and induced myocardial dilatation and fibrosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22733458","rdfs:label":"CTF1 treatment in rats","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c36c4459-297d-4ada-8c6f-be006f18ad89","type":"EvidenceLine","dc:description":"No functional data available for this variant. Sufficiently rare in the general population (TOPMed 0.00001). Clinvar - 1 entry likely benign. Variant doesn't alter AA residue. Patient has variants in MYBPC3 and ABCC9 as alternative explanation for disease.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c36c4459-297d-4ada-8c6f-be006f18ad89_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/f48b34c3-2236-4de0-aa6a-90c705349c7d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.468C>T (p.Ala156=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133729"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2cd9c07d-de30-4d54-b22f-894bd78bff8f","type":"EvidenceLine","dc:description":"No functional data available for this variant. Variant is frequent (ExAC 0.00341) in the general population. Clinvar - most interpretations benign or likely benign. Doesn't alter AA residue.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cd9c07d-de30-4d54-b22f-894bd78bff8f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d6a8c9f-1dc1-4f23-af0b-ea0dec861046","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.591C>G (p.Pro197=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133735"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/97472885-0381-4104-8104-d4d839e243a3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97472885-0381-4104-8104-d4d839e243a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/0bbd31aa-973b-407e-874f-9d4e0df5253a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.341G>A (p.Arg114His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133726"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8968db0c-1a80-4fbf-973a-73be39abf84a","type":"EvidenceLine","dc:description":"No functional data available for this variant. Variant is frequent (ExAC 0.00341) in the general population. Clinvar - most interpretations benign or likely benign. Doesn't alter AA residue.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8968db0c-1a80-4fbf-973a-73be39abf84a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d6a8c9f-1dc1-4f23-af0b-ea0dec861046"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1f33b47d-4fe4-4238-8122-51c313af7c34","type":"EvidenceLine","dc:description":"Score reduced to 0 due to MAF>0.0001","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f33b47d-4fe4-4238-8122-51c313af7c34_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11058912","allele":{"id":"https://genegraph.clinicalgenome.org/r/5075e66a-2b7f-4767-81bc-c8604192b7ac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.274G>A (p.Ala92Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133720"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ef19cc13-543b-451e-b278-ec1fc04f694c_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b269e16-4e43-4838-8657-59b85138c1e6","type":"EvidenceLine","dc:description":"Case control method used for analysis of one promoter variant g.983G>T only (ClinGen allele registry number CA280569026). Found in 10/208 DCM cases and 3/204 healthy blood donor control samples. However this variant is common (gnomAD allele frequency 165), overall case control evidence scored as 0.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b269e16-4e43-4838-8657-59b85138c1e6_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11058912","rdfs:label":"Erdmann et al. cohort","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/8df71fda-cfe5-407c-8da0-1057258d4d98","type":"Cohort","allGenotypedSequenced":208,"alleleFrequency":0.04807692307692308,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b269e16-4e43-4838-8657-59b85138c1e6_cc_evidence_item"}],"numWithVariant":10,"relatedCondition":{"id":"obo:MONDO_0005021"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/00db6eb7-c77b-4805-91b5-a8111dba422a","type":"Cohort","allGenotypedSequenced":204,"alleleFrequency":0.01470588235294118,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b269e16-4e43-4838-8657-59b85138c1e6_cc_evidence_item"}],"numWithVariant":3},"lowerConfidenceLimit":0.81,"method":{"id":"cg:SingleVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValue":3.01,"statisticalSignificanceValueType":"Odds Ratio","upperConfidenceLimit":11.2}],"specifiedBy":"GeneValidityCaseControlSingleVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1aeb26e0-8731-462b-8431-bb3bfa0c0be7","type":"EvidenceLine","dc:description":"No functional data available for this variant. Sufficiently rare in the general population (ExaC 0.00008). Clinvar reports - 1 likely benign and 1 VUS. Variant doesn't alter splice site. This patient also has a MYBPC3 VUS as an alternate explanation for disease.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1aeb26e0-8731-462b-8431-bb3bfa0c0be7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/53515c4d-f5ad-41b9-9cf9-3f6acf17ea23","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.144+7G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133716"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d833bf88-1c89-4c98-9f94-cc57e054a3e9","type":"EvidenceLine","dc:description":"No functional data available for this variant. Variant is frequent (ExAC 0.00341) in the general population. Clinvar - most interpretations benign or likely benign. Doesn't alter AA residue.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d833bf88-1c89-4c98-9f94-cc57e054a3e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d6a8c9f-1dc1-4f23-af0b-ea0dec861046"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e17957c4-7f5d-454a-82cb-25f699b2c1ab","type":"EvidenceLine","dc:description":"No functional data available for this variant. Variant is sufficiently rare in the general population (ExAC 0.00055). Individual has alternative genetic cause for disease (1 ACTN2 variant and 40 TTN variants). Clinvar 3 entries as VUS. Variant doesn't alter coding sequence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e17957c4-7f5d-454a-82cb-25f699b2c1ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc138809-9e48-414f-ae8d-73e3a43d25b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.*5C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133712"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f86b6b19-22a8-4849-8a8d-2575d8e36e22","type":"EvidenceLine","dc:description":"No functional data available for this variant. Sufficiently rare in the general population (gnomAD 0.00048). Clinvar - 3 entries all likely benign. Variant doesn't alter AA residue. Patient has variants in NEXN and TTN as alternative explanation for disease.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f86b6b19-22a8-4849-8a8d-2575d8e36e22_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/32058377-88e4-4fb5-a67b-fafbe80ad548","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001330.5(CTF1):c.280C>T (p.Leu94=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133723"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.1}],"evidenceStrength":"Limited","sequence":8781,"specifiedBy":"GeneValidityCriteria10","strengthScore":2.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/tV66w-07REM","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:2499","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ef19cc13-543b-451e-b278-ec1fc04f694c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}